These names are displaying both technical and quantitative deterioration.
Don't be in a rush. The key to accumulating stocks in this environment is to move incrementally.
A fresh look at the budding hydroponic supplier.
While HRVSF has navigated through numerous changes and delivered solid revenue, litigation issues are piling up.
GRWG has no meaningful competition. The companies in the space are one-third the size and not competing on the same national scale.
Here are two tech-infused names to watch this year.
Many in the cannabis industry have been surmising that states will look to cannabis to plug any budget shortfalls.
Psychedelic companies hoping to capitalize on a surging interest in psilocybin treatments have been limited to one source for research grade psilocybin. Until now.
The big question is how does this action resolve itself?
Real Money tapped an industry expert to discuss the outlook for buying and selling of cannabis companies.